001     148628
005     20240229123033.0
024 7 _ |a 10.1038/s41564-019-0594-3
|2 doi
024 7 _ |a pmid:31686029
|2 pmid
024 7 _ |a altmetric:69761566
|2 altmetric
037 _ _ |a DKFZ-2019-03173
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Stanifer, Megan
|0 P:(DE-He78)8c3dd76230733f354d346a2fbe8db355
|b 0
|e First author
|u dkfz
245 _ _ |a Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells.
260 _ _ |a London
|c 2020
|b Nature Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1601364192_28911
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Jan;5(1):181-191#EA:F140#LA:F140#
520 _ _ |a Intestinal epithelial cells (IECs) act as a physical barrier separating the commensal-containing intestinal tract from the sterile interior. These cells have found a complex balance allowing them to be prepared for pathogen attacks while still tolerating the presence of bacterial or viral stimuli present in the lumen of the gut. Using primary human IECs, we probed the mechanisms that allow for such a tolerance. We discovered that viral infections emanating from the basolateral side of IECs elicit a stronger intrinsic immune response in comparison to lumenal apical infections. We determined that this asymmetric immune response is driven by the clathrin-sorting adaptor AP-1B, which mediates the polarized sorting of Toll-like receptor 3 (TLR3) towards the basolateral side of IECs. Mice and human IECs lacking AP-1B showed an exacerbated immune response following apical stimulation. Together, these results suggest a model where the cellular polarity program plays an integral role in the ability of IECs to partially tolerate apical commensals while remaining fully responsive to invasive basolateral pathogens.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Mukenhirn, Markus
|0 P:(DE-He78)bd6d0f168fa320c13e2027b273602455
|b 1
700 1 _ |a Muenchau, Stephanie
|0 P:(DE-He78)e66515a6be60877d105f7b2f95b81141
|b 2
700 1 _ |a Pervolaraki, Kalliopi
|0 P:(DE-He78)744dfecf3314a45f295ee7cbf7630a57
|b 3
700 1 _ |a Kanaya, Takashi
|b 4
700 1 _ |a Albrecht, Dorothee
|0 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa
|b 5
700 1 _ |a Odendall, Charlotte
|b 6
700 1 _ |a Hielscher, Thomas
|0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
|b 7
700 1 _ |a Haucke, Volker
|0 0000-0003-3119-6993
|b 8
700 1 _ |a Kagan, Jonathan C
|b 9
700 1 _ |a Bartfeld, Sina
|0 0000-0003-2493-8282
|b 10
700 1 _ |a Ohno, Hiroshi
|0 0000-0001-8776-9661
|b 11
700 1 _ |a Boulant, Steeve
|0 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
|b 12
|e Last author
|u dkfz
773 _ _ |a 10.1038/s41564-019-0594-3
|0 PERI:(DE-600)2845610-5
|n 1
|p 181-191
|t Nature microbiology
|v 5
|y 2020
|x 2058-5276
909 C O |p VDB
|o oai:inrepo02.dkfz.de:148628
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)8c3dd76230733f354d346a2fbe8db355
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)bd6d0f168fa320c13e2027b273602455
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e66515a6be60877d105f7b2f95b81141
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)744dfecf3314a45f295ee7cbf7630a57
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)6d885f5506bfb36244e75a3a016af7fa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT MICROBIOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT MICROBIOL : 2017
920 2 _ |0 I:(DE-He78)F140-20160331
|k F140
|l F140 Zelluläre Polarität und virale Infektion
|x 0
920 0 _ |0 I:(DE-He78)F140-20160331
|k F140
|l F140 Zelluläre Polarität und virale Infektion
|x 0
920 1 _ |0 I:(DE-He78)F140-20160331
|k F140
|l F140 Zelluläre Polarität und virale Infektion
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F140-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21